Regulatory
FDA Approves Gilead’s Bixlenvo, the Smallest Once-Daily Single-Pill HIV Regimen
The bictegravir/lenacapavir tablet gives virologically suppressed adults — including those on complex regimens — a new one-pill, once-a-day option.